8Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis[J]. N Engl J Med, 334(11):693-699. 被引量：1
9Lau WY, Leung TW, Ho SK, et al. Adjuvant intra-arterial iodine-131 labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial [J]. Lancet,1999,353(9155):797-801. 被引量：1
8Departments of Surgical Oncology (Wu FS, Zhao WH, Ma ZM, Teng LS and Wang M) and General Surgery ( Liang TB and Zheng SS) , First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.Survival factors after resection of small hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2005,4(3):379-384. 被引量：5
4American Joint Commiitte on Cancer (ADJJ). ADJJ Cancer Staging Manual, fifth edition. Philadelphia. New York: Lippincott - Raven, 1997.97 - 101. 被引量：1
5Mazzaferro V, Regalia E. Liver transplantation for the treatment of small hepatoceltular carcinomas in patient with cirrohosis. N Engl J Med, 1996,334:693 - 699. 被引量：1
6Gunther EJ, Moody SE, Belka GK et al . Impact of p53 loss on rever and recurrence of conditional Wnt- induced tumorigmesis. Genes Dev,2003,17(4) :488 - 501. 被引量：1
7Bressac B, Kew M, Wands Jet al . Selective G to T mutations of p53 gene in Hepatocarcinoma from sounthem Africa. Nature, 1991,350:429. 被引量：1
8Ebelt J, Neild M, Tannapfel A et al . Prognostic significance of prohferation markers in hepatocelluar carcinoma(HCC).Zentralbl Chir,2000,125(7) :597 - 601. 被引量：1
9Terada T. Ya suni N. Cell proliferative activity in adenomatous hyperplasis of the liver and small Hepatocarcinoma. Cancer 1992,70(3):5991 -5998. 被引量：1
